Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain

Background: Amplification of the MYCN oncogene is the most unfavorable genetic factor in neuroblastoma patients. However, knowledge about the clinical impact of low-level multiplication of MYCN is still insufficient. Therefore, we aimed to investigate the disease course in patients with different co...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Szewczyk, Katarzyna, Wieczorek, Aleksandra, Młynarski, Wojciech, Janczar, Szymon, Woszczyk, Mariola, Gamrot, Zuzanna, Chaber, Radosław, Wysocki, Mariusz, Pogorzała, Monika, Bik-Multanowski, Mirosław, Balwierz, Walentyna
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2019
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794702/
https://ncbi.nlm.nih.gov/pubmed/31649880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01018
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia